We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current E1LV34 market cap is 106.68B. The company's latest EPS is USD 25.4810 and P/E is 15.37.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.85B | 42.65B | 42.58B | 43.89B | 45.11B |
| Operating Income | 1.91B | 1.26B | 3.2B | 3.27B | 1.67B |
| Net Income | 1.29B | 856M | 2.25B | 2.3B | 1.02B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 104.21B | 121.87B | 138.64B | 156.6B | 171.34B |
| Operating Income | 6.73B | 7.06B | 8.74B | 8.62B | 8.75B |
| Net Income | 4.81B | 4.57B | 6.1B | 6.03B | 5.99B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.48B | 108.93B | 111.89B | 112.99B | 116.53B |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.45B | 86.62B | 97.46B | 102.77B | 108.93B |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 106.68B |
| Price to Earnings Ratio | 15.37 |
| Price to Sales Ratio | 0.54 |
| Price to Cash Ratio | 14.1 |
| Price to Book Ratio | 0.84 |
| Dividend Yield | 1.14% |
| Shares Outstanding | 234.96M |
| Average Volume (1 week) | 1.05k |
| Average Volume (1 Month) | 573 |
| 52 Week Change | -18.50% |
| 52 Week High | 638.82 |
| 52 Week Low | 439.96 |
| Spread (Intraday) | 4.4 (0.98%) |
| Company Name | Elevance Health Inc |
| Address |
220 virginia avenue indianapolis, indiana 46204 |
| Website | https://ww.elevancehealth.com |
| Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
